SEZ6L Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA550757-Each-of-1 | In Stock | ₹ 46,502.50 |
PA550757 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
SEZ6L
Classification
Polyclonal
Conjugate
Unconjugated
Gene
SEZ6L
Gene Alias
Acig1; acupuncture induced gene 1; acupuncture-induced protein 1-L; AI843918; AIG1; Aig1l; AW539724; Brain-specific receptor-like protein B; BSRP-B; KIAA0927; mKIAA0927; RGD1563628; seizure 6-like protein; seizure related 6 homolog (mouse)-like; seizure related 6 homolog like; seizure related gene 6-like; Sez6l; UNQ2542/PRO6094
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
23544, 56747
Content And Storage
-20°C
Form
Liquid
Applications
Immunohistochemistry (Paraffin)
Concentration
0.6 mg/mL
Formulation
PBS with 40% glycerol and 0.05% sodium azide; pH 7.4
Gene Accession No.
Q6P1D5, Q9BYH1
Gene Symbols
SEZ6L
Immunogen
Synthetic peptide corresponding to residues near the C terminal of human seizure related 6 homolog (mouse)-like
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse
Product Type
Antibody
Isotype
IgG
Related Products
Description
- The antibody detects endogenous levels of total SEZ6L protein
- SEZ6L (seizure related 6 homolog-like) is a 1,024 amino acid single-pass type I membrane protein that localizes to the endoplasmic reticulum
- Widely expressed, SEZ6L is a candidate tumor suppressor gene and may contribute to specialized endoplasmic reticulum functions in neurons
- SEZ6L contains three CUB domains and five sushi (CCP/SCR) domains, which may be involved in protein-protein interactions and signal transduction
- The gene encoding SEZ6L is located on human chromosome 22, which houses over 500 genes and is the second smallest human chromosome
- Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia.